Head-to-head · Value Score
CoreAge Rx vs TeleHealth Med
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, TeleHealth Med a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameTeleHealth Med
#255 · Grade C · Watch List
Est. first month
From $147/mo (starting dose, compounded)
Save ~89% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. TeleHealth Med isn't out of it: Someone who wants an oral option and has read the refund terms first.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | TeleHealth Med |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | From $147/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $99/mo | From $147/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
TeleHealth Med
TeleHealth Med, Inc. is a Georgia-based platform selling compounded semaglutide from $147 a month in injectable and oral forms, dispensed through 503A pharmacies.
Why it's a deal
- Offers both injectable and sublingual routes on the same account
- Names its operating entity, TeleHealth Med, Inc., with a stated Georgia base
- Links to a LegitScript verification rather than only displaying a badge
- Publishes a refund and cancellation policy at all, which many storefronts here do not
The fine print
- Describes its 503A pharmacies as "regulated by the FDA" — 503A compounders are overseen by state boards; 503B outsourcing facilities are the FDA-registered ones
- No refunds for partially used subscription periods or bundled packages, and nothing already shipped can be refunded
- The specific 503A pharmacy partner is not named
- The full states-served list is not disclosed and no medical director is named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to TeleHealth Med.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.